Lloyds Corporate Litigation Reporter

Merck & Co. Inc. disclosed in its latest Quarterly Report on Form 10-Q filed with the U.S. Securities and Exchange Commission that As of September 30, 2009, the Company had been served or was aware that it had been named…

Merck & Co. Inc. disclosed in its latest Quarterly Report on Form 10-Q filed with the U.S. Securities and Exchange Commission that it is cooperating with governmental entities in Europe in their respective investigations on the company’s Vioxx product.

Investigations are…

Merck & Co. Inc. disclosed in its latest Quarterly Report on Form 10-Q filed with the U.S. Securities and Exchange Commission that it is cooperating with the U.S. Department of Justice regarding a probe centered on its Vioxx product activities.

The…

Merck & Co. Inc. disclosed in its latest Quarterly Report on Form 10-Q filed with the U.S. Securities and Exchange Commission that on September 8, 2009, plaintiff filed a second motion for rehearing en banc regarding the Texas state court…

Pride International Inc. is engaged in discussions with the U.S. Department of Justice and the U.S. Securities and Exchange Commission regarding a potential negotiated resolution of matters relating to its compliance of the U.S. Foreign Corrupt Practices Act, which could…